Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04158622
Other study ID # 19-239
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 15, 2021
Est. completion date December 2022

Study information

Verified date April 2021
Source Unity Health Toronto
Contact Rajeev Muni, MD
Phone 416-867-7411
Email Rajeev.Muni@unityhealth.to
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients may experience metamorphopsia, or image distortion, after having vitrectomy to repair their rhegmatogenous retinal detachments (RRDs) especially those with a detached macula. Retinal displacement, as measured on autofluorescence photography, likely contributes to this distortion. There is no study in the scientific literature comparing the rate of retinal displacement and its association with visual function, including metamorphopsia, in patients undergoing different procedures for RRD repair. Based on the recently published PIVOT trial, patients who underwent Pneumatic Retinopexy (PnR) had less vertical distortion at 12 months than patients who had Pars Plana Vitrectomy (PPV). It is hypothesized that PnR will cause less retinal displacement than PPV for patients with macula-off primary retinal detachment.


Description:

Rhegmatogenous retinal detachments (RRD) are a sight-threatening condition with an incidence of approximately 10 per 100 000 people. RRDs can be broadly classified into those with the macula still attached, and those with the macula detached. Without surgical intervention by a vitreoretinal surgeon, retinal detachment almost invariably results in permanent sight loss. Current techniques for RRD repair include scleral buckle (SB), pneumatic retinopexy (PnR), and pars plana vitrectomy (PPV) with or without combination of SB. Pneumatic retinopexy (PnR) is a minor surgical intervention employed to repair retinal detachments, carried out in the clinic's procedure room. Standard criteria for this procedure include one or more retinal breaks within one clock hour located at the superior eight clock hours, without signs of proliferative vitreoretinopathy. The procedure involves injection of a small gas bubble into the eyeball via a fine needle. Two gases can be injected into the eye: perfluoropropane (C3F8), which lasts 6 weeks, and sulfur hexafluoride (SF6), which lasts about 2 weeks. After injection of the gas bubble, the patient is required to maintain a strict 'head posture' (for example, head tilt to left) for up to 10 days. The gas bubble spontaneously dissipates after 2-6 weeks, depending on the gas selected. Additionally, laser treatment or cryotherapy is carried out either before or 1-2 days after injection of the gas bubble, to secure the retinal tear. The advantages of PnR over PPV are: (1) Low risk of cataract - secondary cataract formation is uncommon after PnR, but more common after PPV; (2) Quicker visual rehabilitation - due to the smaller size gas bubble and less invasive nature of the procedure, patients undergoing PnR commonly have improved vision within days after treatment; (3) Immediate availability of intervention - unlike PPV, PnR is carried out in a treatment room, and there are no delays due to operating room availability. Pars plana vitrectomy (PPV) is a surgical procedure carried out in the operating room under regional anesthetic, and often times sedation. During PPV, the vitreous gel is removed from the eye to allow space for a larger gas bubble than is possible in PnR, and also to relieve any vitreous traction which may otherwise impair reattachment of the retina. The retina is reattached by either draining the subretinal fluid through a peripheral retinal break; by draining the subretinal fluid through a posterior retinotomy; or by using a heavier-than-water liquid such as perfluocarbon (PFC) to push out the subretinal fluid. Laser or cryotherapy is applied around the retinal tear to create chorioretinal adhesions (as in PnR). At the end of the surgery, the vitreous cavity is filled with a substance that will tamponade the retina to the wall of the eye while the adhesions form. Tamponade agents can be temporary, such as SF6 and C3F8 (same gases as mentioned for PnR), which are absorbed by 2-6 weeks, or long term, such as silicone oil, which requires a second surgery to remove. After the surgery, the patient may be required to maintain a 'head posture' (for example, head tilt to left) for up to one week to support the area of the retinal tear optimally by 'floating' the gas bubble up against it. As the gas bubble is larger in PPV, the head posturing requirements are less strict. The advantages of PPV over PnR are: (1) higher primary single procedure success rate (although same final reattachment success rate); (2) less follow-up visits in the first week. Patients may experience metamorphopsia, or image distortion, after having their RRD repaired especially those with a detached macula. In 2010, Shiragami et al were the first to demonstrate hyperfluorescent lines, adjacent to the retinal blood vessels in Fundus autofluorescence imaging (FAF) of the retina after RD repair surgery.They theorized that these lines which are called Retinal Vessel Printings (RVP) correspond to the location of the retinal blood vessels before the retinal detachment. In FAF, an image is taken with structures that naturally fluoresce such as the lipofuscin in the retinal pigment epithelium (RPE) appearing brighter. According to this theory, prior to the retinal detachment, certain RPE cells were covered by the retinal blood vessels. Afterwards, with the displacement of the retina due to the retinal detachment these RPE cells become exposed to light which increases in metabolic activity producing more lipofuscin and therefore, appearing more hyperautofluorescent on the FAF. Moreover, these reference lines allow us to quantify the displacement of the retina after retinal detachment surgeries. In this study by Shiragami, 62.8% of eyes demonstrated hyperautofluorescent lines superior to the retinal blood vessels suggesting downward displacement. Since Shiragami's first report, several other studies looked into retinal displacement after RD repair. There is no study in the scientific literature comparing the rate of retinal displacement and its association with visual function, including metamorphopsia, in patients undergoing different procedures for RRD repair. The aim of this study is to compare retinal displacement following primary macula-off retinal detachment repair treated with pneumatic retinopexy (PnR) versus pars plana vitrectomy (PPV). The primary study hypothesis is that pneumatic retinopexy will cause less retinal displacement at 3 months for patients with macula-off primary retinal detachment.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date December 2022
Est. primary completion date December 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Macula-off retinal detachment - Single retinal break OR group of breaks no larger than four clock hours apart between each other (Figure 2) - All breaks in detached retina must be between 3-9 o'clock (Figure 2, blue lines) - No significant proliferative vitreoretinopathy (PVR) (can have grade A or B) Exclusion Criteria: - Inferior breaks in detached retina. NOTE: Patient can have any number, location and size of retinal breaks or lattice degeneration in attached retina. - Inability to read English language - Age < 18 years - Mental incapacity - Previous vitrectomy (index eye) - Previous retinal detachment (index eye) - Previous or concurrent retina pathology (e.g. vascular) - Previous or concurrent macula pathology (macular hole, ERM, AMD, DME) - Anterior segment surgery within 3 months - Inability to maintain post intervention head positioning - Inability to carry out detailed examination of the peripheral retina due to media opacity NOTE: Lens/posterior hyaloid status does not impact eligibility.

Study Design


Intervention

Procedure:
PnR + laser/cryotherapy
Pneumatic retinopexy plus laser/cryotherapy
PPV + laser/cryotherapy
Pars plana vitrectomy plus laser/cryotherapy

Locations

Country Name City State
Canada St. Michael's Hospital Eye Clinic Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
Unity Health Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Retinal Displacement Retinal displacement by the presence of retinal vessels printing on FAF imaging 3 months post intervention
Secondary Visual acuity (ETDRS) The Early Treatment of Diabetic Retinopathy Study (ETDRS) developed a vision chart that has now become the gold standard for measuring visual function in ophthalmic research. 3, 6, and 12 months post intervention
Secondary Objective Metamorphopsia Metamorphopsia assessed by M-CHARTS, which measures the minimum visual angle of a dotted line needed to detect metamorphopsia. 3, 6, and 12 months post intervention
Secondary Subjective Metamorphopsia Metamorphopsia Questionnaire; The Questionnaire is a valid tool to assess patient's subjective perception of metamorphopsia. The minimum score is 0 and maximum score is 3, and higher scores mean a worse outcome. 3, 6, and 12 months post intervention
Secondary Aniseikonia Test Aniseikonia Test measures the ratio of image size difference between the 2 eyes. 3, 6, and 12 months post intervention
Secondary Optical Coherence Tomography (OCT) cystoid macular edema (CME) Two readers will analyze the cross-sectional OCT images regarding the presence of CME. 3, 6, and 12 months post intervention
Secondary Optical Coherence Tomography (OCT) layers disruption Two readers will analyze the cross-sectional OCT images regarding the presence of retinal layers disruption. 3, 6, and 12 months post intervention
Secondary Optical Coherence Tomography (OCT) retinal folds Two readers will analyze the cross-sectional OCT images regarding the presence of outer/inner retinal folds. 3, 6, and 12 months post intervention
Secondary Optical Coherence Tomography Angiography (OCTA) capillary perfusion Two readers will analyze OCTA images regarding retinal capillary plexuses perfusion. 3, 6, and 12 months post intervention
Secondary Optical Coherence Tomography Angiography (OCTA) changes Two readers will analyze OCTA images regarding area of foveal avascular zone. 3, 6, and 12 months post intervention
Secondary Association between retinal displacement (RVP) and visual function (ETDRS) Association between the presence of retinal displacement and ETDRS values. 3 months post intervention
See also
  Status Clinical Trial Phase
Completed NCT03332758 - Inflammasomes in Cell Death in FTMH, ERM, and RRD
Completed NCT03660384 - Silicone Oil Versus Gas in PDR Patients Undergoing Vitrectomy N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT04535622 - Efficacy of Exercise Program for Facedown Posture-related Pain After Retinal Surgery N/A
Recruiting NCT05863312 - REtinal Detachment Outcomes Study N/A
Recruiting NCT05561569 - Air Versus Gas Tamponade in Primary Retinal Detachment N/A
Not yet recruiting NCT05538156 - Internal Limiting Membrane Peeling in Retinal Detachment Surgery N/A
Completed NCT03046719 - Subconjunctiva Bupivacaine as Analgesia in Intravitreal Silicone Oil Removal N/A
Recruiting NCT01261533 - Flexibility, Efficacy, and Safety of a Foldable Capsular Vitreous Body in the Treatment of Severe Retinal Detachment Phase 1
Terminated NCT02068625 - Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment Phase 4
Completed NCT00000140 - The Silicone Study Phase 3
Recruiting NCT05543018 - Effect of Intraocular Tamponade on Visual Perception N/A
Not yet recruiting NCT04518696 - Suprachoroidal Buckling for the Management of Rhegmatogenous Retinal Detachment N/A
Completed NCT03321253 - Changes of Macular Pigment and Parameters of Eyes After YAG Laser Treatment in Cases With Capsule Opacification N/A
Completed NCT06166914 - Efficacy of 5-fluorouracil and Low Molecular Weight Heparin in High-risk Pediatric Retinal Detachment N/A
Enrolling by invitation NCT05566626 - Retinal Oxygenation Estimation Trial With Mantis Photonics Hyperspectral Camera N/A
Not yet recruiting NCT03631108 - Feasibility Study and Preliminary Application Study on Iris OCTA
Recruiting NCT02201706 - Multi-electrocoagulation Retinectomy for Retinal Re-detachment in Silicone Oil Filled Eye N/A
Completed NCT03218371 - Scleral Self-indentation Chandelier-assisted Peripheral Vitrectomy Under Air Rhegmatogenous Retinal Detachment. N/A
Completed NCT00000154 - Diabetic Retinopathy Vitrectomy Study (DRVS) Phase 3